Mar 08, 2022 / 01:30PM GMT
Operator
Good morning, and welcome to Voyager Therapeutics Fourth Quarter and Full Year 2021 Conference Call. (Operator Instructions) Please be advised this call is being recorded at the company's request.
I would now like to turn the call over to Julie Burek, Vice President of Finance at Voyager.
Julie Burek - Voyager Therapeutics, Inc. - Principal Financial & Accounting Officer
Thank you, operator. Good morning, everyone, and welcome to this conference call to discuss our most recent license option agreement and to review our fourth quarter and full year 2021 results, both announced this morning. A replay of today's call will be available on the Investors section of our website approximately 2 hours after completion of this call.
After our prepared remarks, we will open the call for Q&A.
As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform
Q4 2021 Voyager Therapeutics Inc Earnings Call Transcript
Mar 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers